The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Mechanisms of thrombosis in obesity
Open accessAbstract
PURPOSE OF REVIEW: Obesity has become a worldwide epidemic that is driving increased morbidity and mortality from thrombotic disorders such as myocardial infarction, stroke, and venous thromboembolism. Effective prevention and treatment of thrombosis in obese patients is limited by an incomplete understanding of the underlying prothrombotic mechanisms and by uncertainties about risks, benefits, and dosing of anticoagulant drugs in this patient population. RECENT FINDINGS: This review summarizes our current understanding of established and emerging mechanisms contributing to the obesity-induced prothrombotic state. The mechanistic impact of chronic inflammation and impaired fibrinolysis in mediating obesity-associated thrombosis is highlighted. Recent data demonstrating the aberrant expression of adipokines and microRNAs, which appear to function as key modulators of proinflammatory and prothrombotic pathways in obesity, are also reviewed. Finally, some challenges and new approaches to the prevention and management of thrombotic disorders in obese and overweight patients are discussed. SUMMARY: Obesity-driven chronic inflammation and impaired fibrinolysis appear to be major effector mechanisms of thrombosis in obesity. The proinflammatory and hypofibrinolytic effects of obesity may be exacerbated by dysregulated expression and secretion of adipokines and microRNAs, which further increase the risk of thrombosis and suggest new potential targets for therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedPositional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828124ad · Cited by 5,292
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
Mammalian microRNAs predominantly act to decrease target mRNA levels
Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Yusuf, S., Hawken, S., Ôunpuu, S., Bautista, L., Franzosi, M. G., Commerford, P., Lang, C. C., Rumboldt, Z., Onen, C. L., Lisheng, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67663-5 · Cited by 2,903
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
Novel Modulator for Endothelial Adhesion Molecules: Adipocyte-Derived Plasma Protein Adiponectin
Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., et al. (1999) · Circulation · doi:10.1161/01.cir.100.25.2473 · Cited by 2,147
Platelets and the immune continuum
Semple, J. W., Italiano, J. E., & Freedman, J. (2011) · Nature Reviews Immunology · doi:10.1038/nri2956 · Cited by 1,692
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
Zampetaki, A., Kiechl, S., Drozdov, I., Willeit, P., Mayr, U., Prokopi, M., Mayr, A., Weger, S., Oberhollenzer, F., Bonora, E., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.226357 · Cited by 1,283
Garcia, D. A., Baglin, T. P., Weitz, J. I., & Samama, M. M. (2012) · Chest · doi:10.1378/chest.11-2291 · Cited by 1,091
MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1
Harris, T. A., Yamakuchi, M., Ferlito, M., Mendell, J. T., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707493105 · Cited by 1,010
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.003 · Cited by 911
Apelin, a Newly Identified Adipokine Up-Regulated by Insulin and Obesity
Boucher, J., Masri, B., Daviaud, D., Gesta, S., Guigné, C., Mazzucotelli, A., Castan-Laurell, I., Tack, I., Knibiehler, B., Carpéné, C., et al. (2005) · Endocrinology · doi:10.1210/en.2004-1427 · Cited by 910
Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty
Shimomura, I., Funahasm, T., Takahashi, M., Maeda, K., Kotani, K., Nakamura, T., Yamashita, S., Miura, M., Fukuda, Y., Takemura, K., et al. (1996) · Nature Medicine · doi:10.1038/nm0796-800 · Cited by 890
Wallace, A. M., McMahon, A. D., Packard, C. J., Kelly, A., Shepherd, J., Gaw, A., & Sattar, N. (2001) · Circulation · doi:10.1161/hc5001.101061 · Cited by 825
The complex transcriptional landscape of the anucleate human platelet
Bray, P. F., McKenzie, S. E., Edelstein, L. C., Nagalla, S., Delgrosso, K., Ertel, A., Kupper, J., Jing, Y., Londin, E., Loher, P., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-1 · Cited by 802
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
Rayner, K. J., Esau, C. C., Hussain, F. N., McDaniel, A. L., Marshall, S. M., van Gils, J. M., Ray, T. D., Sheedy, F. J., Goedeke, L., Liu, X., et al. (2011) · Nature · doi:10.1038/nature10486 · Cited by 706
Arita, Y., Kihara, S., Ouchi, N., Maeda, K., Kuriyama, H., Okamoto, Y., Kumada, M., Hotta, K., Nishida, M., Takahashi, M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000018622.84402.ff · Cited by 695
Resistin Promotes Endothelial Cell Activation: Further Evidence of Adipokine-Endothelial Interaction
Verma, S., Li, S.-H., Wang, C.-H., Fedak, P. W. M., Li, R.-K., Weisel, R. D., & Mickle, D. A. G. (2003) · Circulation · doi:10.1161/01.cir.0000084503.91330.49 · Cited by 670
JNK Expression by Macrophages Promotes Obesity-Induced Insulin Resistance and Inflammation
Han, M. S., Jung, D. Y., Morel, C., Lakhani, S. A., Kim, J. K., Flavell, R. A., & Davis, R. J. (2013) · Science · doi:10.1126/science.1227568 · Cited by 636
A Prospective Study of Body Mass Index, Weight Change, and Risk of Stroke in Women
Rexrode, K. M. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540430051032 · Cited by 617
Obesity as a risk factor in venous thromboembolism
Stein, P. D., Beemath, A., & Olson, R. E. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.03.012 · Cited by 592
Kumada, M., Kihara, S., Ouchi, N., Kobayashi, H., Okamoto, Y., Ohashi, K., Maeda, K., Nagaretani, H., Kishida, K., Maeda, N., et al. (2004) · Circulation · doi:10.1161/01.cir.0000127953.98131.ed · Cited by 555
The Role of Adipose Tissue and Adipokines in Obesity-Related Inflammatory Diseases
Balistreri, C. R., Caruso, C., & Candore, G. (2010) · Mediators of Inflammation · doi:10.1155/2010/802078 · Cited by 550
Existence of a microRNA pathway in anucleate platelets
Landry, P., Plante, I., Ouellet, D. L., Perron, M. P., Rousseau, G., & Provost, P. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1651 · Cited by 487
MicroRNA history: Discovery, recent applications, and next frontiers
Almeida, M. I., Reis, R. M., & Calin, G. A. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.03.009 · Cited by 466
Dahl, T. B., Yndestad, A., Skjelland, M., Øie, E., Dahl, A., Michelsen, A., Damås, J. K., Tunheim, S. H., Ueland, T., Smith, C., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.665893 · Cited by 465
Abdominal Obesity and Risk of Ischemic Stroke: The Northern Manhattan Stroke Study
Suk, S.-H., Sacco, R. L., Boden-Albala, B., Cheun, J. F., Pittman, J. G., Elkind, M. S., & Paik, M. C. (2003) · Stroke · doi:10.1161/01.str.0000075294.98582.2f · Cited by 420
Konstantinides, S., Schäfer, K., Koschnick, S., & Loskutoff, D. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13143 · Cited by 373
Circulating microRNAs as novel biomarkers for platelet activation.
Willeit, P., Zampetaki, A., Dudek, K., Kaudewitz, D., King, A., Kirkby, N. S., Crosby-Nwaobi, R., Prokopi, M., Drozdov, I., Langley, S. R., et al. (2013) · Circulation Research · doi:10.1161/circresaha.111.300539 · Cited by 365
Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b
Kornfeld, J.-W., Baitzel, C., Könner, A. C., Nicholls, H. T., Vogt, M. C., Herrmanns, K., Scheja, L., Haumaitre, C., Wolf, A. M., Knippschild, U., et al. (2013) · Nature · doi:10.1038/nature11793 · Cited by 349
Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity
Nagalla, S., Shaw, C., Kong, X., Kondkar, A. A., Edelstein, L. C., Ma, L., Chen, J., McKnight, G. S., López, J. A., Yang, L., et al. (2011) · Blood · doi:10.1182/blood-2010-09-299719 · Cited by 329
Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis
Chun, H. J., Ali, Z. A., Kojima, Y., Kundu, R. K., Sheikh, A. Y., Agrawal, R., Zheng, L., Leeper, N. J., Pearl, N. E., Patterson, A. J., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34871 · Cited by 329
Kim, S.-R., Bae, Y.-H., Bae, S.-K., Choi, K.-S., Yoon, K.-H., Koo, T. H., Jang, H.-O., Yun, I., Kim, K.-W., Kwon, Y.-G., et al. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.004 · Cited by 316
Anti-inflammatory therapeutics for the treatment of atherosclerosis
Charo, I. F., & Taub, R. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3444 · Cited by 306
Samad, F., Yamamoto, K., & Loskutoff, D. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118404 · Cited by 301
MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment
Quiat, D., & Olson, E. N. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62876 · Cited by 300
Castan-Laurell, I., Dray, C., Attané, C., Duparc, T., Knauf, C., & Valet, P. (2011) · Endocrine · doi:10.1007/s12020-011-9507-9 · Cited by 297
Leptin revisited: its mechanism of action and potential for treating diabetes
Coppari, R., & Bjørbæk, C. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3757 · Cited by 293
Role of adipokines in cardiovascular disease
Mattu, H. S., & Randeva, H. S. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0232 · Cited by 292
Leal, V. D. O., & Mafra, D. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.02.003 · Cited by 277
Eyries, M., Siegfried, G., Ciumas, M., Montagne, K., Agrapart, M., Lebrin, F., & Soubrier, F. (2008) · Circulation Research · doi:10.1161/circresaha.108.179333 · Cited by 268
Ouedraogo, R., Gong, Y., Berzins, B., Wu, X., Mahadev, K., Hough, K., Chan, L., Goldstein, B. J., & Scalia, R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29623 · Cited by 264
Role of microRNAs in diabetes and its cardiovascular complications
Shantikumar, S., Caporali, A., & Emanueli, C. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvr300 · Cited by 263
Single-Stranded siRNAs Activate RNAi in Animals
Lima, W. F., Prakash, T. P., Murray, H. M., Kinberger, G. A., Li, W., Chappell, A. E., Li, C. S., Murray, S. F., Gaus, H., Seth, P. P., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.014 · Cited by 256
APJ acts as a dual receptor in cardiac hypertrophy
Scimia, M. C., Hurtado, C., Ray, S., Metzler, S., Wei, K., Wang, J., Woods, C. E., Purcell, N. H., Catalucci, D., Akasaka, T., et al. (2012) · Nature · doi:10.1038/nature11263 · Cited by 250
Leptin promotes aggregation of human platelets via the long form of its receptor.
Nakata, M., Yada, T., Soejima, N., & Maruyama, I. (1999) · Diabetes · doi:10.2337/diabetes.48.2.426 · Cited by 244
Plasma leptin and prognosis in patients with established coronary atherosclerosis
Wolk, R., Berger, P., Lennon, R. J., Brilakis, E. S., Johnson, B. D., & Somers, V. K. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.050 · Cited by 235
Effect of Leptin on Arterial Thrombosis Following Vascular Injury in Mice
Bodary, P. F. (2002) · JAMA · doi:10.1001/jama.287.13.1706 · Cited by 224
Endogenous regulation of cardiovascular function by apelin-APJ
Charo, D. N., Ho, M., Fajardo, G., Kawana, M., Kundu, R. K., Sheikh, A. Y., Finsterbach, T. P., Leeper, N. J., Ernst, K. V., Chen, M. M., et al. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00686.2009 · Cited by 205
KONDKAR, A. A., BRAY, M. S., LEAL, S. M., NAGALLA, S., LIU, D. J., JIN, Y., DONG, J. F., REN, Q., WHITEHEART, S. W., SHAW, C., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03700.x · Cited by 197
Hypercoagulability in the metabolic syndrome
Nieuwdorp, M., Stroes, E. S., Meijers, J. C., & Büller, H. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.10.003 · Cited by 190
Tissue Distribution and Regulation of Plasminogen Activator Inhibitor-1 in Obese Mice
Samad, F., & Loskutoff, D. J. (1996) · Molecular Medicine · doi:10.1007/bf03401641 · Cited by 188
Fleissner, F., Jazbutyte, V., Fiedler, J., Gupta, S. K., Yin, X., Xu, Q., Galuppo, P., Kneitz, S., Mayr, M., Ertl, G., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.216770 · Cited by 186
Visfatin/NAMPT: A Multifaceted Molecule with Diverse Roles in Physiology and Pathophysiology
Dahl, T. B., Holm, S., Aukrust, P., & Halvorsen, B. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071811-150746 · Cited by 185
Wolk, R., Berger, P., Lennon, R. J., Brilakis, E. S., & Somers, V. K. (2003) · Circulation · doi:10.1161/01.cir.0000095270.85646.e8 · Cited by 184
Payne, G. A., Borbouse, L., Kumar, S., Neeb, Z., Alloosh, M., Sturek, M., & Tune, J. D. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.210070 · Cited by 182
The Effect of Sodium Salicylate and Aspirin on NF-κB
Frantz, B., & O’Neill, E. A. (1995) · Science · doi:10.1126/science.270.5244.2017 · Cited by 153
Infections and inflammatory diseases as risk factors for venous thrombosis: A systematic review
Kluin‐Nelemans, H. C., Meijer, K., & Tichelaar, Y. I. G. V. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-09-0611 · Cited by 148
Body Mass Index, Surgery, and Risk of Venous Thromboembolism in Middle-Aged Women: A Cohort Study
Parkin, L., Sweetland, S., Balkwill, A., Green, J., REEVES, G. K., & Beral, V. (2012) · Circulation · doi:10.1161/circulationaha.111.063354 · Cited by 147
Leptin Induces C-Reactive Protein Expression in Vascular Endothelial Cells
Singh, P., Hoffmann, M., Wolk, R. A., Shamsuzzaman, A., & Somers, V. K. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.148353 · Cited by 140
Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia
Kidoya, H., Naito, H., & Takakura, N. (2010) · Blood · doi:10.1182/blood-2009-07-232306 · Cited by 139
Freedman, J. E., Larson, M. G., Tanrıverdi, K., O’Donnell, C. J., Morin, K. M., Hakanson, A. S., Vasan, R. S., Johnson, A. D., Iafrati, M. D., & Benjamin, E. J. (2010) · Circulation · doi:10.1161/circulationaha.109.928192 · Cited by 138
Tissue factor in infection and severe inflammation
Levi, M., van der Poll, T., & ten Cate, H. (2006) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2006-933338 · Cited by 126
Adiponectin Is Required for PPARγ-Mediated Improvement of Endothelial Function in Diabetic Mice
Wong, W. T., Tian, X. Y., Xu, A., Yu, J. Q., Lau, C. W., Hoo, R. L. C., Wang, Y., Lee, V. W. Y., Lam, K. S. L., Vanhoutte, P. M., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.05.009 · Cited by 126
Translational promise of the apelin–APJ system
Barnes, G. D., Japp, A. G., & Newby, D. E. (2010) · Heart · doi:10.1136/hrt.2009.191122 · Cited by 120
Pan, J., Xia, L., & McEver, R. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.10058 · Cited by 111
Siddiquee, K., Hampton, J. P., Khan, S., Zadory, D., Gleaves, L. A., Vaughan, D. E., & Smith, L. H. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834347de · Cited by 108
Infection and Inflammation as Risk Factors for Thrombosis and Atherosclerosis
Levi, M. M., van der Poll, T., & Schultz, M. J. (2012) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0032-1305782 · Cited by 100
miR-421 and miR-30c Inhibit SERPINE 1 Gene Expression in Human Endothelial Cells
Marchand, A., Proust, C., Morange, P., Lompré, A., & Trégouët, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044532 · Cited by 70
Cardiovascular effects of a PEGylated apelin
Jia, Z. Q., Hou, L., Leger, A., Wu, I., Kudej, A. B., Stefano, J. E., Jiang, C., Pan, C. Q., & Akita, G. Y. (2012) · Peptides · doi:10.1016/j.peptides.2012.09.003 · Cited by 58
Role of fibrinolysis in obesity and thrombosis
LIJNEN, H. R. (2009) · Thrombosis Research · doi:10.1016/s0049-3848(09)70143-4 · Cited by 56
NAGAI, N., HOEF, B. V., & LIJNEN, H. R. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02631.x · Cited by 52
Belalcazar, L. M., Ballantyne, C. M., Lang, W., Haffner, S. M., Rushing, J., Schwenke, D. C., Pi-Sunyer, X., & Tracy, R. P. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.224386 · Cited by 49
Alessi, M., Nicaud, V., Scroyen, I., Lange, C., Saut, N., Fumeron, F., Marre, M., Lantieri, O., Fontaine‐Bisson, B., Juhan-Vague, I., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-03-0179 · Cited by 42
Dellas, C., Schäfer, K., Rohm, I., et al. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-03-0213 · Cited by 42
Chen, Y., Zhang, L.-Q., Wang, G., Zeng, H., Lü, B., Shen, X., Jiang, Z., & Chen, F. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-02-0124 · Cited by 38
Singh, A., Foster, G. D., Gunawardana, J., McCoy, T. A., Nguyen, T. T.-T. N., Veur, S. S. V., Komaroff, E., & Rao, A. K. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09160.x · Cited by 34
McLean, D. L., Kim, J., Kang, Y., Shi, H., Atkins, G. B., Jain, M. K., & Chun, H. J. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300317 · Cited by 33
Therapeutic use of recombinant methionyl human leptin
Vatier, C., Gautier, J., & Vigouroux, C. (2012) · Biochimie · doi:10.1016/j.biochi.2012.03.013 · Cited by 29
Okamoto, Y., Ishii, S., Croce, K., Katsumata, H., Fukushima, M., Kihara, S., Libby, P., & Minami, S. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.12.012 · Cited by 26
Cited by
Obesity: Risk factors, complications, and strategies for sustainable long‐term weight management
Fruh, S. M. (2017) · Journal of the American Association of Nurse Practitioners · doi:10.1002/2327-6924.12510 · Cited by 709
Global pandemics interconnected — obesity, impaired metabolic health and COVID-19
Stefan, N., Birkenfeld, A. L., & Schulze, M. B. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00462-1 · Cited by 452
Metformin: Mechanisms in Human Obesity and Weight Loss
Yerevanian, A., & Soukas, A. A. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00335-3 · Cited by 414
Metabolic Syndrome Pathophysiology and Predisposing Factors
Bovolini, A., Garcia, J., Andrade, M. A., & Duarte, J. A. (2021) · International Journal of Sports Medicine · doi:10.1055/a-1263-0898 · Cited by 385
The Role of Inflammation in Venous Thromboembolism
Branchford, B. R., & Carpenter, S. L. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00142 · Cited by 384
Metadata
- Authors
- Blokhin, I. O., & Lentz, S. R.
- Venue
- Current Opinion in Hematology
- Published
- 2013-09
- Volume
- 20
- Issue
- 5
- Pages
- 437-444
- ISSN
- 1065-6251 (ISSN-L)
- OpenAlex
- W2055210821
- Cited by
- 345
- References
- 88
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.